Skip to content

Allen & Overy advises Riverside on sale of its stake in ACTINEO

Related people
Krueger Astrid
Dr Astrid Krüger

Partner

Munich

View profile →

Tobias Hugo

Senior Associate

Munich

View profile →

Hendrik Roehricht
Dr Hendrik Röhricht

Partner

Munich

View profile →

Press contacts

For media enquiries relating to this topic, please contact:

Harald Klett
Harald Klett

Manager PR & Communications

Frankfurt am Main

View profile →

29 October 2021

Allen & Overy has advised global investor The Riverside Company (Riverside) on the divestment of its majority share in ACTINEO, the German market leader for the digitisation and medical assessment of bodily injury claims, to US data analytics provider Verisk Analytics Inc. (Verisk).

ACTINEO, headquartered in Cologne, Germany, operates in Germany, Austria, France, Spain and Italy and provides holistic data management and software-based solutions to support insurance companies in managing the entire bodily injury claims process. Riverside invested in ACTINEO in mid-2019. Its divestment from the company includes ACTINEO’s stake in the French joint venture ANTEVIS SAS, which specialises in innovative digital services for the medical codification and assessment of bodily injury claims in the field of medical malpractice liability.

Verisk, based in Jersey City, New Jersey, is a leading global data analytics provider serving customers in insurance, energy, financial services, and specialised markets.

Riverside, a global private investor, is focusing on investments in growth companies with a value of up to 400 million US dollars. Since its launch in 1988, Riverside has executed more than 800 investments. The firm’s international investments through its private equity and structured capital portfolios encompass more than 140 companies.

The team of Allen & Overy was led by partner Dr Astrid Krueger and senior associate Tobias Hugo (both Corporate/M&A/Private Equity, Munich), and further comprised partners Dr Hendrik Roehricht (Corporate/M&A/Private Equity, Munich), Dr Heike Weber (Tax), Dr Udo Olgemoeller (Public Law, both Frankfurt), Dr Jens Matthes (IP, Dusseldorf), as well as counsel Dr Sebastian Schulz (Employment & Benefits, Frankfurt). Further advice has been provided by senior associates Tobias Hugo (Corporate/M&A/Private Equity, Munich) and Heiner Mecklenburg (Antitrust, Hamburg), as well as associates Johannes Grassl, Adriana Worms (both Corporate/M&A/Private Equity, Munich) and Dr Manuel Koechel (Tax, Frankfurt).

The management of ACTINEO was further advised by Achim Thywissen (General Counsel).